序号 |
标题 |
次数 |
作者 |
发布时间 |
74296 |
Maleimide-(CH2)5-COONHS cas:55750-63-5 6-(马来酰亚胺基)己酸琥珀酰亚胺酯 |
99 |
zyl |
2024-12-18 |
74297 |
DOTA-cetuximab DOTA-西妥昔单抗 |
105 |
h |
2024-12-18 |
74298 |
DOTA-CAIX-P1-4-10 大环配体DOTA修饰靶向碳酸酐酶IX的多肽探针 |
96 |
h |
2024-12-18 |
74299 |
三七皂苷脂质体,PNS-Lip,靶向脂质体定制服务 |
109 |
axc |
2024-12-18 |
74300 |
HS-C15-COOH 巯基-C15-羧基 |
127 |
zyl |
2024-12-18 |
74301 |
MC-VC-PAB-N3, ADC试剂 |
100 |
kx |
2024-12-18 |
74302 |
DSPE-PEG-四氮杂环配体 DSPE-PEG-tetranitroheterocyclic ligand DSPE-PEG-DOTA |
119 |
h |
2024-12-18 |
74303 |
1639939-40-4,MC-Val-Ala-PAB-PNP,ADC定制 |
117 |
wyh |
2024-12-18 |
74304 |
丝裂霉素C-全氟溴辛烷脂质体,PFOB@Lip-MMC,提供荧光脂质体定制服务 |
96 |
axc |
2024-12-18 |
74305 |
HS-(CH2)5-EG2-Biotin 巯基-五烷烃-二聚乙二醇-生物素 |
86 |
zyl |
2024-12-18 |
74306 |
MA-PEG4-Ala-Ala-PAB-PNP,MA-四聚乙二醇-ALA-ALA-PAB-PNP |
82 |
kx |
2024-12-18 |
74307 |
Ac-Nle-Asp-His-D-Phe-Arg-Trp-Gly-Lys(DOTA)-NH2 |
96 |
h |
2024-12-18 |
74308 |
1020112-73-5,2-氨基-1,3-双(羧乙氧基)丙烷盐酸盐,ADC定制 |
71 |
wyh |
2024-12-18 |
74309 |
DOTA-8-Aoc-BBN(7-14)NH2 |
70 |
h |
2024-12-18 |
74310 |
Fmoc-PEG4-Val-Ala-PAB,一种肽合成中常用的保护基 |
91 |
WYQ |
2024-12-18 |
74311 |
盐酸多柔比星脂质体,DOX-Lip,脂质体纳米载体定制服务 |
100 |
axc |
2024-12-18 |
74312 |
Gd-DOTA偶联甘草次酸(GGD) |
137 |
h |
2024-12-18 |
74313 |
HS-(CH2)3-EG12-OCH2-COOH 巯基-3烷烃-十二聚乙二醇-OCH2-羧基 |
100 |
zyl |
2024-12-18 |
74314 |
cas:2055024-55-8,Boc-PEG2-Val-Cit-PAB-OH,ADC定制 |
107 |
wyh |
2024-12-18 |
74315 |
阿仑膦酸钠(ALN)脂质体,多功能载药脂质体定制服务 |
199 |
axc |
2024-12-18 |
74316 |
KGDS多肽修饰的人铁蛋白负载DOTA KGDS-FRT-DOTA |
98 |
h |
2024-12-18 |
74317 |
Fmoc-Val-Ala-PAB-PNP,CAS号:1394238-92-6 |
94 |
WYQ |
2024-12-18 |
74318 |
钆卟啉(Gd-TP)负载石墨烯量子点修饰环肽RGD |
75 |
h |
2024-12-18 |
74319 |
Fmoc-Phe-Lys(Boc)-PAB, ADC试剂 |
75 |
kx |
2024-12-18 |
74320 |
HS-(CH2)11-EG2-NH3+ Cl- 巯基-十一烷烃-二聚乙二醇-NH3+ Cl- |
92 |
zyl |
2024-12-18 |
74321 |
顺铂脂质复合物脂质体,CDDP-MM,载药脂质体定制服务 |
79 |
axc |
2024-12-18 |
74322 |
MWCNT/PEI-FI-DOTA(Gd)-mPEG5K |
86 |
h |
2024-12-18 |
74323 |
Fmoc-PEG4-Val-Ala-PAB-PNP,一种高效且可控的多肽合成技术 |
101 |
WYQ |
2024-12-18 |
74324 |
寡聚透明质酸修饰的鞣花酸脂质体,EA-HA-L,靶向脂质体定制服务 |
111 |
axc |
2024-12-18 |
74325 |
Boc-PEG4-Val-Ala-PAB,一种可降解的ADC连接体 |
93 |
WYQ |
2024-12-18 |
74326 |
双-甲苯磺酸-(2-羟乙基二硫化物),Bis-Tos-(2-hydroxyethyl disulfide),ADC定制 |
97 |
wyh |
2024-12-18 |
74327 |
Fmoc-Arg(boc)2-PAB-OH, ADC试剂 |
120 |
kx |
2024-12-18 |
74328 |
Boc-Val-Ala-PAB-PNP,CAS号:1884578-00-0 |
77 |
WYQ |
2024-12-18 |
74329 |
中性粒细胞膜修饰吲哚菁绿脂质体纳米探针,Neu-Lipo-ICG,提供荧光脂质体定制服务 |
177 |
axc |
2024-12-18 |
74330 |
864235-83-6,Fmoc-NH-ethyl-SS-propionic acid,ADC定制 |
75 |
wyh |
2024-12-18 |
74331 |
Boc-PEG4-Val-Ala-PAB-PNP,1884578-00-0 |
72 |
WYQ |
2024-12-18 |
74332 |
159857-70-2,MC-Val-Cit-Doxorubicin,MC-VAL-CIT-阿霉素 |
134 |
kx |
2024-12-18 |
74333 |
替米考星脂质体,TMS-Lip,多功能载药脂质体定制服务 |
88 |
axc |
2024-12-18 |
74334 |
ODDA-Sgc8-c-DOTA DOTA修饰核酸适体与脂肪酸偶联物 |
75 |
h |
2024-12-18 |
74335 |
HS-(CH2)m-EGn-OH 巯基-烷烃-聚乙二醇-羟基 |
86 |
zyl |
2024-12-18 |
74336 |
cas:159858-22-7 ,Fmoc-Val-Cit-PAB-OH |
74 |
kx |
2024-12-18 |
74337 |
(Au)G5.NHDOTAPEGNi 硝基咪唑修饰功能化树状大分子G5.NHDOTA偶联金纳米颗粒 |
99 |
h |
2024-12-18 |
74338 |
Fmoc-Val-Ala-OH,N-[芴甲氧羰基]-L-缬氨酰-L-丙氨酸,150114-97-9。 |
203 |
WYQ |
2024-12-18 |
74339 |
桑椹花色苷脂质体,载药脂质体定制服务 |
87 |
axc |
2024-12-18 |
74340 |
DOTANHS修饰第五代聚酰胺胺树状大分子 DOTANHSG5 |
89 |
h |
2024-12-18 |